ifenprodil has been researched along with donepezil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sen, S; Sinha, N | 1 |
| Catenacci, L; Cavaletti, G; Collina, S; Coniglio, S; Curti, D; Liedl, KR; Malacrida, A; Monteleone, S; Pace, V; Paolillo, M; Rossi, D; Rossino, G; Rui, M; Schepmann, D; Scuteri, A; Sorrenti, M; Urban, E; Venturini, L; Wünsch, B | 1 |
| Hashimoto, K | 1 |
1 review(s) available for ifenprodil and donepezil
| Article | Year |
|---|---|
Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication.
Topics: Animals; Donepezil; Humans; Indans; Mental Disorders; Models, Neurological; Neurotransmitter Agents; Piperidines; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor | 2015 |
2 other study(ies) available for ifenprodil and donepezil
| Article | Year |
|---|---|
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents.
Topics: Acetylcholinesterase; Animals; Antioxidants; Blood-Brain Barrier; Cell Survival; Cholinesterase Inhibitors; Guinea Pigs; Humans; Mice; Molecular Docking Simulation; Neurodegenerative Diseases; Neuroprotective Agents; Rats; Reactive Oxygen Species; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries | 2018 |